<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>NCI CTCAE v5.0 hepatobiliary toxicity</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">NCI CTCAE v5.0 hepatobiliary toxicity</h1>
<div class="graphic"><div class="figure"><div class="ttl">NCI CTCAE v5.0 hepatobiliary toxicity</div><div class="cntnt"><table cellspacing="0"><colgroup span="6" width="16%"></colgroup> <tbody> <tr> <td class="subtitle1">Adverse event</td> <td class="subtitle1">Grade 1</td> <td class="subtitle1">Grade 2</td> <td class="subtitle1">Grade 3</td> <td class="subtitle1">Grade 4</td> <td class="subtitle1">Grade 5</td> </tr> <tr class="divider_bottom"> <td>Alkaline phosphatase increased</td> <td>&gt;ULN to 2.5 x ULN if baseline was normal; 2 to 2.5 x baseline if baseline was abnormal</td> <td>&gt;2.5 to 5 x ULN if baseline was normal; &gt;2.5 to 5 x baseline if baseline was abnormal</td> <td>&gt;5 to 20 x ULN if baseline was normal; &gt;5 to 20 x baseline if baseline was abnormal</td> <td>&gt;20 x ULN if baseline was normal; &gt;20 x baseline if baseline was abnormal</td> <td> </td> </tr> <tr class="divider_bottom"> <td>Alanine aminotransferase increased</td> <td>&gt;ULN to 3 x ULN if baseline was normal; 1.5 to 3 x baseline if baseline was abnormal</td> <td>&gt;3 to 5 x ULN if baseline was normal; &gt;3 to 5 x baseline if baseline was abnormal</td> <td>&gt;5 to 20 x ULN if baseline was normal; &gt;5 to 20 x baseline if baseline was abnormal</td> <td>&gt;20 x ULN if baseline was normal; &gt;20 x baseline if baseline was abnormal</td> <td> </td> </tr> <tr class="divider_bottom"> <td>Aspartate aminotransferase increased</td> <td>&gt;ULN to 3 x ULN if baseline was normal; 1.5 to 3 x baseline if baseline was abnormal</td> <td>&gt;3 to 5 x ULN if baseline was normal; &gt;3 to 5 x baseline if baseline was abnormal</td> <td>&gt;5 to 20 x ULN if baseline was normal; &gt;5 to 20 x baseline if baseline was abnormal</td> <td>&gt;20 x ULN if baseline was normal; &gt;20 x baseline if baseline was abnormal</td> <td> </td> </tr> <tr class="divider_bottom"> <td>Blood bilirubin increased</td> <td>&gt;ULN to 1.5 x ULN if baseline was normal; &gt;1 to 1.5 x baseline if baseline was abnormal</td> <td>&gt;1.5 to 3 x ULN if baseline was normal; &gt;1.5 to 3 x baseline if baseline was abnormal</td> <td>&gt;3 to 10 x ULN if baseline was normal; &gt;3 to 10 x baseline if baseline was abnormal</td> <td>&gt;10 x ULN if baseline was normal; &gt;10 x baseline if baseline was abnormal</td> <td> </td> </tr> <tr class="divider_bottom"> <td>GGT increased</td> <td>&gt;ULN to 2.5 x ULN if baseline was normal; 2 to 2.5 x baseline if baseline was abnormal</td> <td>&gt;2.5 to 5 x ULN if baseline was normal; &gt;2.5 to 5 x baseline if baseline was abnormal</td> <td>&gt;5 to 20 x ULN if baseline was normal; &gt;5 to 20 x baseline if baseline was abnormal</td> <td>&gt;20 x ULN if baseline was normal; &gt;20 x baseline if baseline was abnormal</td> <td> </td> </tr> <tr class="divider_bottom"> <td>Hepatic failure</td> <td> </td> <td> </td> <td>Asterixis; mild encephalopathy; drug-induced liver injury (DILI); limiting self-care ADL*</td> <td>Life-threatening consequences; moderate to severe encephalopathy; coma</td> <td>Death</td> </tr> <tr> <td>Portal hypertension</td> <td> </td> <td>Decreased portal vein flow</td> <td>Reversal/retrograde portal vein flow associated with varices and/or ascites</td> <td>Life-threatening consequences; urgent intervention needed</td> <td>Death</td> </tr> </tbody></table></div><div class="graphic_lgnd">The laboratory findings (ie, increased alkaline phosphatase, bilirubin, GGT, aspartate aminotransferase [also called AST or SGOT], and alanine aminotransferase [also called ALT or SGPT]) are graded separately under "Investigations" in the source document. Hepatic failure, characterized by the inability of the liver to metabolize chemicals in the body, and portal hypertension, characterized by an increase in blood pressure in the portal venous system, are graded under hepatobiliary disorders.</div><div class="graphic_footnotes">NCI CTCAE: National Cancer Institute Common Terminology Criteria for Adverse Events; ULN: upper limit of normal; GGT: gamma-glutamyl transpeptidase (also called gamma-glutamyl transferase); DILI: drug-induced liver injury; ADL: activities of daily living.<br/>* DILI is defined by Hy's law; refer to text for details. Self-care ADLs include bathing, dressing/undressing, using the toilet, taking medications, and not bedridden.</div><div class="graphic_reference">Reproduced from: Common Terminology Criteria for Adverse Events (CTCAE), Version 5.0, November 2017, National Institutes of Health, National Cancer Institute. Available at: <a href="https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf" target="_blank">https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf</a> (Accessed March 27, 2018).</div><div id="graphicVersion">Graphic 77533 Version 12.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
